Founded in 2008 in Suzhou, China, by a group of industrial and academic veterans with extensive experience in drug discovery and development, 3D BioOptima strives to best serve our clients with value-added solutions for their drug R&D programs of chemical and biological therapeutics by conducting specialized preclinical services, such as absorption, distribution, metabolism and excretion (ADME) characterization, pharmacokinetic and pharmacodynamic evaluation, bioanalysis, high-throughput ADME screening, ADME-assisted lead optimization, and regulatory consultation. 3D BioOptima has a 33,000-sq ft advanced preclinical facility that is equipped with state-of-the-art instruments and integrated with a 10,000-sq ft high-standard vivarium.
3D BioOptima’s mission is to help our clients to solve their R&D problems and bring their drugs to the market as quickly and cost effectively as possible. Our vision is to be a leading provider in integrated preclinical services by contributing quality, innovation, and responsiveness to the pharmaceutical industry.
To learn more about 3D BioOptima, please visit www.3dbiooptima.com.
苏州圣苏新药开发有限公司（3D BioOptima）成立于2008年，公司核心团队由在药物的研究开发领域有着丰富经验的工业及学术界专家组成。圣苏主要业务是为国内外制药企业的药物研发提供专业化的化学及生物药物临床前研究，主要包括生物分析、体外ADMET（吸收、分布、代谢、排泄及毒理）筛选、体内ADME研究、基于ADMET研究的先导化合物优化、药物/毒物动力学、药动-药效结合模型、大分子药物动力学以及常规的新药临床前研究咨询等服务。公司目前有约3000平方米的临床前实验场地包括约1000平方米的动物实验室，拥有各种先进的实验设备包括液质联用仪、自动化液体工作站、超速离心机等等。
圣苏公司的宗旨是为客户提供最优质的研发技术服务，并帮助他们节省开支，缩短研发周期，早日实现新药的上市。公司的目标是通过优质服务，大胆创新，及对制药企业的快速回应，争取在临床前及临床药物研发技术服务领域处于领先地位。
想了解更多圣苏的信息，请登录www.3dbiooptima.com。
